Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Cocrystal Pharma, Inc. is a biotechnology company focused on discovering and developing antiviral therapeutics targeting RNA viruses such as influenza, coronaviruses, norovirus, and hepatitis C. Utilizing proprietary structure-based drug design, it aims to create safe, effective, broad-spectrum, and resistance-high barrier antiviral drugs. Its core activities include preclinical and clinical research, with a focus on unmet medical needs in infectious diseases. The company relies on collaborations, third-party manufacturing, and advanced scientific platforms to develop innovative antiviral treatments.
This description was generated via AI from an annual report. Updated about 1 year ago.